CUPR Market Analysis

Overview

Fundamentals

P/E ratio
EPS (TTM)$-0.180.0% YoY
Profit margin0.0%HEALTHCARE
Market cap$5.4MMicro cap

Valuation

Forward P/E
PEG ratio
P/B
1.37
P/S (TTM)
108.42
EV/EBITDA

Profitability & growth

ROE (TTM)
-1569.0%
Operating margin
-10568.0%
Revenue growth YoY
267.4%
Dividend yield
Beta
Last earnings
Dec 9, 2025 · Estimate $0.00 · Reported $-0.10
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Page 1 of 2 · 36 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Cuprina Holdings (Cayman) Limited Class A Ordinary Shares

Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds.

Classification

Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
BLK 1090, SINGAPORE, SINGAPORE
Fiscal year end
December
Latest quarter
Dec 31, 2025
Market cap$5.4M
Shares outstanding$7.4M
52W high$9.50
52W low$0.24

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer